TNFSF13B and B-cell chronic lymphocytic leukemia: Analyses of ATP levels using CellTiterGlo® (CTG; Promega, Madison, WI, USA) assays revealed that BAFF dose-dependently protected CLL cells from drug-induced cell death (Figure 1A and data not shown).